CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

Alto Neuroscience has raised $100 million through an underwritten registered [...]

Skyhawk Therapeutics has expanded its global pivotal Phase 2/3 clinical [...]

Vect-Horus has entered a research collaboration and exclusive licence option [...]

Emalex Biosciences has received FDA authorisation for an Expanded Access [...]

Celon Pharma S.A. has received FDA clearance to advance its [...]